Phase II evaluation of weekly docetaxel in combination with weekly carboplatin in the treatment of recurrent epithelial ovarian carcinoma

Trial Profile

Phase II evaluation of weekly docetaxel in combination with weekly carboplatin in the treatment of recurrent epithelial ovarian carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2007

At a glance

  • Drugs Carboplatin; Docetaxel
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 07 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top